Epithalon is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of Epithalon is not established. This means dosing once daily for 10-20 day cycles is typical to maintain stable levels. The half-life directly affects how long Epithalon remains active and influences optimal injection timing.
What Is the Half-Life of Epithalon?
The half-life of Epithalon is not established. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer Epithalon to maintain therapeutic blood levels.
What Does Epithalon's Half-Life Mean for Dosing?
With a half-life of not established, Epithalon requires dosing once daily for 10-20 day cycles to maintain stable levels. The standard dosage of 5-10 mg daily via subcutaneous injection or intranasal accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, Epithalon reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For Epithalon, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject Epithalon?
Optimal timing depends on your research goals. A half-life of not established means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily for 10-20 day cycles) for more stable levels throughout the day.
How Does Epithalon's Half-Life Compare to Similar Peptides?
Epithalon is a Geroprotective peptide, telomerase activator. Its half-life of not established positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your Epithalon Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Epithalon.
Open Calculator →Bottom Line: Epithalon Half-Life and Dosing
Epithalon has a half-life of not established, supporting the standard protocol of 5-10 mg daily dosed once daily for 10-20 day cycles over 10-20 days, repeated 2-3 times per year.
Read our Epithalon dosage guide for complete protocol details.
Complete Guide
Epithalon (Epitalon): Longevity Peptide Research
Related Reading
- Epithalon Dosage Guide
- Epithalon Benefits
- Epithalon Side Effects
- Epithalon Stacking Guide
- Epithalon Cycle Guide
- Epithalon Research
Research-Grade Sourcing
If you're going to research Epithalon, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Epithalon?
Epithalon (Tetrapeptide Ala-Glu-Asp-Gly (AEDG)) is a Geroprotective peptide, telomerase activator. Synthesized based on the amino acid composition of bovine pineal extract (Epithalamin), designed to activate telomerase. It is researched for telomere lengthening, anti-aging effects, improved immune function, melatonin regulation, oxidative stress reduction, cellular rejuvenation.
What is the recommended Epithalon dosage?
Common dosages: 5-10 mg daily administered once daily for 10-20 day cycles via subcutaneous injection or intranasal. Cycle length: 10-20 days, repeated 2-3 times per year. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Epithalon?
Excellent safety profile across clinical studies. Minimal reported adverse effects. Well-tolerated at established doses.
Is Epithalon safe?
Epithalon has shown a favorable safety profile in research. Not FDA-approved in USA. Approved in Russia and some Eastern European countries as anti-aging pharmaceutical. All research should follow appropriate safety protocols.